Ionis Pharmaceuticals is eyeing a…
Ionis Pharmaceuticals is eyeing a new rare disease approval after [...]
It’s been less than two years…
It’s been less than two years since Roche dove into [...]
The German drug developer has…
The German drug developer has tapped four industry leaders to [...]
Renowned biotech veteran Robert…
Renowned biotech veteran Robert Langer is the executive chair of [...]
After Carisma Therapeutics laid…
After Carisma Therapeutics laid off 95% of its team earlier [...]
Biogen has given Alcyone…
Biogen has given Alcyone Therapeutics a starring role in its [...]
VectorY Therapeutics has seen the…
VectorY Therapeutics has seen the shape of things to come—and [...]
Having already stripped back their…
Having already stripped back their development plans for the estrogen [...]
Roche dived into the metabolic…
Roche dived into the metabolic dysfunction-associated steatohepatitis space by agreeing [...]
Beijing QL Biopharmaceutical has…
Beijing QL Biopharmaceutical has shared phase 2 data on its [...]